Companies Contributing Hematology Diagnostics Market to Achieve 3.6% CAGR from 2021 to 2027

The global Hematology Diagnostics market was valued at US$ 2121.2 million in 2020 and is expected to reach US$ 2730.1 million by the end of 2027, growing at a CAGR of 3.6% during 2021-2027.

Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets.

Hematology testing devices have come a long way from disease detection and monitoring to counting and characterizing blood cells. The concept of automation has extended to detect small cell populations in order to diagnose rare blood conditions, which requires less labor, rapid result, and easy-to-use analyzers. Current technologies include automation of hematology analyzer, electrical impedance, flow cytometry, and fluorescent flow.

Global Hematology Diagnostics Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Hematology Diagnostics Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.

Key Companies profiled in this report are Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche, Beckman Coulter and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.

Find more details at:

Segment by Type

  • Hematology Instruments
  • Hematology Consumables

Segment by Application

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Institutes
  • Others

Table of Content:

1 Hematology Diagnostics Market Overview

2 Hematology Diagnostics Market Competition by Manufacturers

3 Hematology Diagnostics Retrospective Market Scenario by Region

4 Global Hematology Diagnostics Historic Market Analysis by Type

5 Global Hematology Diagnostics Historic Market Analysis by Application

6 Key Companies Profiled

7 Hematology Diagnostics Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Hematology Diagnostics Market Dynamics

10 Global Hematology Diagnostics Market Forecast

11 Research Finding and Conclusion

12 Methodology and Data Source

Media Contact

Company Name: The Market Reports

Contact Person: Shirish Gupta


Phone: +1-631-407-1315